The acquisition of Novonate’s flagship product, LifeBubble, grows Laborie’s Obstetrics, Gynecology and Neonatal portfolio.
PORTSMOUTH, N.H., Feb. 14, 2023 /PRNewswire/ — Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced that it has acquired Novonate, Inc. (Novonate) and its LifeBubble technology, a device that revolutionizes umbilical catheter protection and securement to improve safety for neonates in the intensive care setting.
Founded in 2017, Novonate is a medical device company based in South San Francisco, CA. The company developed LifeBubble after seeing an unserved need in the Neonatal Intensive Care Unit (NICU). Each year in the U.S., more than 200,000 babies require umbilical cord catheters to receive nutrients and medicine1. Typically, umbilical catheters are held in place with tape and adhesive, a method that increases the risk of complications and infections. The LifeBubble umbilical catheter securement system offers a safe, innovative, and user-friendly method that allows for easy positioning and removal while protecting the insertion site.
“At Laborie, we believe that great healthcare is an essential safeguard of human dignity and we are focused on improving the standard of care for patients. LifeBubble is the first product in the world designed to more effectively secure and protect umbilical catheters, improving health outcomes for newborns,” said Nikki Bruce, Vice President and General Manager of Laborie’s OB Business Unit. “We are pleased to add the technology to our Obstetrics, Gynecology and Neonatal portfolio.”